These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34106957)

  • 1. SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1.
    Shepley-McTaggart A; Sagum CA; Oliva I; Rybakovsky E; DiGuilio K; Liang J; Bedford MT; Cassel J; Sudol M; Mullin JM; Harty RN
    PLoS One; 2021; 16(6):e0251955. PubMed ID: 34106957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Envelope (E) Protein Interacts with PDZ-Domain-2 of Host Tight Junction Protein ZO1.
    Shepley-McTaggart A; Sagum CA; Oliva I; Rybakovsky E; DiGuilio K; Liang J; Bedford MT; Cassel J; Sudol M; Mullin JM; Harty RN
    bioRxiv; 2020 Dec; ():. PubMed ID: 33398268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDZ2-conjugated-PLGA nanoparticles are tiny heroes in the battle against SARS-CoV-2.
    Giacon N; Lo Cascio E; Pennacchietti V; De Maio F; Santarelli G; Sibilia D; Tiberio F; Sanguinetti M; Lattanzi W; Toto A; Arcovito A
    Sci Rep; 2024 Jun; 14(1):13059. PubMed ID: 38844490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus Virulence.
    Honrubia JM; Valverde JR; Muñoz-Santos D; Ripoll-Gómez J; de la Blanca N; Izquierdo J; Villarejo-Torres M; Marchena-Pasero A; Rueda-Huélamo M; Nombela I; Ruiz-Yuste M; Zuñiga S; Sola I; Enjuanes L
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short sequence in the tail of SARS-CoV-2 envelope protein controls accessibility of its PDZ-binding motif to the cytoplasm.
    Neitthoffer B; Alvarez F; Larrous F; Caillet-Saguy C; Etienne-Manneville S; Boëda B
    J Biol Chem; 2024 Jan; 300(1):105575. PubMed ID: 38110034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different electrostatic forces drive the binding kinetics of SARS-CoV, SARS-CoV-2 and MERS-CoV Envelope proteins with the PDZ2 domain of ZO1.
    Pennacchietti V; Toto A
    Sci Rep; 2023 May; 13(1):7906. PubMed ID: 37193746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host PDZ-containing proteins targeted by SARS-CoV-2.
    Caillet-Saguy C; Durbesson F; Rezelj VV; Gogl G; Tran QD; Twizere JC; Vignuzzi M; Vincentelli R; Wolff N
    FEBS J; 2021 Sep; 288(17):5148-5162. PubMed ID: 33864728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain.
    Javorsky A; Humbert PO; Kvansakul M
    Commun Biol; 2021 Jun; 4(1):724. PubMed ID: 34117354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein.
    Toto A; Ma S; Malagrinò F; Visconti L; Pagano L; Stromgaard K; Gianni S
    Protein Sci; 2020 Oct; 29(10):2038-2042. PubMed ID: 32822073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis.
    Teoh KT; Siu YL; Chan WL; Schlüter MA; Liu CJ; Peiris JS; Bruzzone R; Margolis B; Nal B
    Mol Biol Cell; 2010 Nov; 21(22):3838-52. PubMed ID: 20861307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells.
    Miura K; Suzuki Y; Ishida K; Arakawa M; Wu H; Fujioka Y; Emi A; Maeda K; Hamajima R; Nakano T; Tenno T; Hiroaki H; Morita E
    J Virol; 2023 Oct; 97(10):e0042623. PubMed ID: 37830820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.
    Alam I; Kamau AA; Kulmanov M; Jaremko Ł; Arold ST; Pain A; Gojobori T; Duarte CM
    Front Cell Infect Microbiol; 2020; 10():405. PubMed ID: 32850499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain-swapped dimerization of the second PDZ domain of ZO2 may provide a structural basis for the polymerization of claudins.
    Wu J; Yang Y; Zhang J; Ji P; Du W; Jiang P; Xie D; Huang H; Wu M; Zhang G; Wu J; Shi Y
    J Biol Chem; 2007 Dec; 282(49):35988-99. PubMed ID: 17897942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-Loaded Virion Endangers GPCR Signaling: Mechanistic Exploration of SARS-CoV-2 Infections and Pharmacological Implications.
    Zhang Q; Friedman PA
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated replication and damaging effects of SARS-CoV-2 Omicron variants in an intestinal epithelial barrier model.
    Volcic M; Nchioua R; Pastorio C; Zech F; Haußmann I; Sauter D; Read C; Walther P; Kirchhoff F
    J Med Virol; 2024 Jul; 96(7):e29783. PubMed ID: 38965890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose of baicalin or baicalein can reduce tight junction integrity by partly targeting the first PDZ domain of zonula occludens-1 (ZO-1).
    Hisada M; Hiranuma M; Nakashima M; Goda N; Tenno T; Hiroaki H
    Eur J Pharmacol; 2020 Nov; 887():173436. PubMed ID: 32745606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis.
    De Maio F; Lo Cascio E; Babini G; Sali M; Della Longa S; Tilocca B; Roncada P; Arcovito A; Sanguinetti M; Scambia G; Urbani A
    Microbes Infect; 2020; 22(10):592-597. PubMed ID: 32891874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis.
    Jimenez-Guardeño JM; Nieto-Torres JL; DeDiego ML; Regla-Nava JA; Fernandez-Delgado R; Castaño-Rodriguez C; Enjuanes L
    PLoS Pathog; 2014 Aug; 10(8):e1004320. PubMed ID: 25122212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.
    Boson B; Legros V; Zhou B; Siret E; Mathieu C; Cosset FL; Lavillette D; Denolly S
    J Biol Chem; 2021; 296():100111. PubMed ID: 33229438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.
    Xia B; Shen X; He Y; Pan X; Liu FL; Wang Y; Yang F; Fang S; Wu Y; Duan Z; Zuo X; Xie Z; Jiang X; Xu L; Chi H; Li S; Meng Q; Zhou H; Zhou Y; Cheng X; Xin X; Jin L; Zhang HL; Yu DD; Li MH; Feng XL; Chen J; Jiang H; Xiao G; Zheng YT; Zhang LK; Shen J; Li J; Gao Z
    Cell Res; 2021 Aug; 31(8):847-860. PubMed ID: 34112954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.